Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Modelling cervical cancer elimination.

Baussano I, Bray F.

Lancet Public Health. 2018 Oct 1. pii: S2468-2667(18)30189-0. doi: 10.1016/S2468-2667(18)30189-0. [Epub ahead of print] No abstract available.

2.

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Lehtinen M, Luostarinen T, Vänskä S, Söderlund-Strand A, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Nieminen P, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 Nov 1;143(9):2299-2310. doi: 10.1002/ijc.31618. Epub 2018 Aug 10.

PMID:
29845626
3.

Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.

Umulisa MC, Franceschi S, Baussano I, Tenet V, Uwimbabazi M, Rugwizangoga B, Heideman DAM, Uyterlinde AM, Darragh TM, Snijders PJF, Sayinzoga F, Clifford GM.

BMC Womens Health. 2018 Apr 24;18(1):59. doi: 10.1186/s12905-018-0549-5.

4.

Impacts of human papillomavirus vaccination for different populations: A modeling study.

Baussano I, Lazzarato F, Ronco G, Franceschi S.

Int J Cancer. 2018 Sep 1;143(5):1086-1092. doi: 10.1002/ijc.31409. Epub 2018 Apr 16.

5.

Options for design of real-world impact studies of single-dose vaccine schedules.

Franceschi S, Clifford GM, Baussano I.

Vaccine. 2018 Aug 6;36(32 Pt A):4816-4822. doi: 10.1016/j.vaccine.2018.02.002. Epub 2018 Mar 21.

6.

Causal system modelling of cervical cancer screening.

Ronco G, Baussano I.

Lancet Public Health. 2017 Feb;2(2):e61-e62. doi: 10.1016/S2468-2667(17)30013-0. Epub 2017 Feb 7. No abstract available.

7.

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.

Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C.

Lancet Public Health. 2016 Nov;1(1):e8-e17. doi: 10.1016/S2468-2667(16)30001-9. Epub 2016 Sep 27. Review.

8.

Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan.

Tshomo U, Franceschi S, Tshokey T, Tobgay T, Baussano I, Tenet V, Heideman DAM, Snijders PJF, Clifford GM.

Oncotarget. 2017 Aug 2;8(42):72438-72446. doi: 10.18632/oncotarget.19783. eCollection 2017 Sep 22.

9.

Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).

Lehtinen M, Söderlund-Strand A, Vänskä S, Luostarinen T, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 Mar 1;142(5):949-958. doi: 10.1002/ijc.31119. Epub 2017 Nov 9.

PMID:
29055031
10.

Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.

Baussano I, Lazzarato F, Ronco G, Lehtinen M, Dillner J, Franceschi S.

J Infect Dis. 2017 Aug 1;216(3):336-344. doi: 10.1093/infdis/jix299.

11.

Cervical cancer screening in rural Bhutan with the careHPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan).

Baussano I, Tshering S, Choden T, Lazzarato F, Tenet V, Plummer M, Franceschi S, Clifford GM, Tshomo U.

BMJ Open. 2017 Jul 19;7(7):e016309. doi: 10.1136/bmjopen-2017-016309.

12.

Effect of age-difference between heterosexual partners on risk of cervical cancer and human papillomavirus infection.

Baussano I, Diaz M, Tully S, Muñoz N, de Sanjosé S, Bosch FX, Franceschi S.

Papillomavirus Res. 2017 Jun;3:98-104. doi: 10.1016/j.pvr.2017.03.003. Epub 2017 Mar 19.

13.

Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan.

Tshomo U, Franceschi S, Tshokey T, Tobgay T, Baussano I, Tenet V, Snijders PJ, Gheit T, Tommasino M, Vorsters A, Clifford GM.

Virol J. 2017 Apr 8;14(1):74. doi: 10.1186/s12985-017-0744-2.

14.

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme.

Ngabo F, Franceschi S, Baussano I, Umulisa MC, Snijders PJ, Uyterlinde AM, Lazzarato F, Tenet V, Gatera M, Binagwaho A, Clifford GM.

BMC Infect Dis. 2016 May 24;16:225. doi: 10.1186/s12879-016-1539-6.

15.

Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.

Franceschi S, Chantal Umulisa M, Tshomo U, Gheit T, Baussano I, Tenet V, Tshokey T, Gatera M, Ngabo F, Van Damme P, Snijders PJ, Tommasino M, Vorsters A, Clifford GM.

Int J Cancer. 2016 Aug 1;139(3):518-26. doi: 10.1002/ijc.30092. Epub 2016 Apr 15.

16.

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior.

Baussano I, Lazzarato F, Brisson M, Franceschi S.

Emerg Infect Dis. 2016 Jan;22(1):18-23. doi: 10.3201/eid2201.150791.

17.

Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus.

Lemieux-Mellouki P, Drolet M, Brisson J, Franco EL, Boily MC, Baussano I, Brisson M.

Epidemiol Infect. 2016 May;144(7):1490-9. doi: 10.1017/S0950268815002915. Epub 2015 Nov 20.

18.

HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Bosch FX, Robles C, Díaz M, Arbyn M, Baussano I, Clavel C, Ronco G, Dillner J, Lehtinen M, Petry KU, Poljak M, Kjaer SK, Meijer CJ, Garland SM, Salmerón J, Castellsagué X, Bruni L, de Sanjosé S, Cuzick J.

Nat Rev Clin Oncol. 2016 Feb;13(2):119-32. doi: 10.1038/nrclinonc.2015.146. Epub 2015 Sep 1. Review.

PMID:
26323382
19.

Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs.

Elfström KM, Lazzarato F, Franceschi S, Dillner J, Baussano I.

J Infect Dis. 2016 Jan 15;213(2):199-205. doi: 10.1093/infdis/jiv368. Epub 2015 Jul 3.

PMID:
26142436
20.

Introduction of a National HPV vaccination program into Bhutan.

Dorji T, Tshomo U, Phuntsho S, Tamang TD, Tshokey T, Baussano I, Franceschi S, Clifford G.

Vaccine. 2015 Jul 17;33(31):3726-30. doi: 10.1016/j.vaccine.2015.05.078. Epub 2015 Jun 6.

PMID:
26057136
21.

Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial.

Lehtinen M, Apter D, Baussano I, Eriksson T, Natunen K, Paavonen J, Vänskä S, Bi D, David MP, Datta S, Struyf F, Jenkins D, Pukkala E, Garnett G, Dubin G.

Vaccine. 2015 Mar 3;33(10):1284-90. doi: 10.1016/j.vaccine.2014.12.019. Epub 2015 Jan 12.

22.

Cervical cancer screening program in Thimphu, Bhutan: population coverage and characteristics associated with screening attendance.

Baussano I, Tshomo U, Clifford GM, Tenet V, Tshokey T, Franceschi S.

BMC Womens Health. 2014 Nov 30;14:147. doi: 10.1186/s12905-014-0147-0.

23.

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme.

Tshomo U, Franceschi S, Dorji D, Baussano I, Tenet V, Snijders PJ, Meijer CJ, Bleeker MC, Gheit T, Tommasino M, Clifford GM.

BMC Infect Dis. 2014 Jul 22;14:408. doi: 10.1186/1471-2334-14-408.

24.

Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era.

Franceschi S, Baussano I.

J Infect Dis. 2014 Aug 15;210(4):507-9. doi: 10.1093/infdis/jiu143. Epub 2014 Mar 8. No abstract available.

PMID:
24610878
25.

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model.

Baussano I, Dillner J, Lazzarato F, Ronco G, Franceschi S.

Infect Agent Cancer. 2014 Jan 20;9(1):4. doi: 10.1186/1750-9378-9-4.

26.

Yield of tuberculosis contact investigation in a low-incidence country.

Borraccino A, Migliore E, Piccioni P, Baussano I, Carosso A, Bugiani M.

J Infect. 2014 May;68(5):448-54. doi: 10.1016/j.jinf.2013.12.005. Epub 2014 Jan 10.

27.

Type-specific human papillomavirus biological features: validated model-based estimates.

Baussano I, Elfström KM, Lazzarato F, Gillio-Tos A, De Marco L, Carozzi F, Del Mistro A, Dillner J, Franceschi S, Ronco G.

PLoS One. 2013 Nov 29;8(11):e81171. doi: 10.1371/journal.pone.0081171. eCollection 2013.

28.

Infection transmission and chronic disease models in the study of infection-associated cancers.

Baussano I, Franceschi S, Plummer M.

Br J Cancer. 2014 Jan 7;110(1):7-11. doi: 10.1038/bjc.2013.740. Epub 2013 Dec 3. Review.

29.

Vaccinating women previously exposed to human papillomavirus: a cost-effectiveness analysis of the bivalent vaccine.

Turner HC, Baussano I, Garnett GP.

PLoS One. 2013 Sep 26;8(9):e75552. doi: 10.1371/journal.pone.0075552. eCollection 2013.

30.

High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991-2010, Italy.

Baussano I, Mercadante S, Pareek M, Lalvani A, Bugiani M.

Emerg Infect Dis. 2013;19(9):1437-45. doi: 10.3201/eid1909.120200.

31.

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial.

Baussano I, Franceschi S, Gillio-Tos A, Carozzi F, Confortini M, Dalla Palma P, De Lillo M, Del Mistro A, De Marco L, Naldoni C, Pierotti P, Schincaglia P, Segnan N, Zorzi M, Giorgi-Rossi P, Ronco G.

BMC Infect Dis. 2013 May 24;13:238. doi: 10.1186/1471-2334-13-238.

32.

Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries.

Baussano I, Lazzarato F, Ronco G, Dillner J, Franceschi S.

Int J Cancer. 2013 Oct 15;133(8):1876-81. doi: 10.1002/ijc.28197. Epub 2013 May 15.

33.

Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya.

De Vuyst H, Chung MH, Baussano I, Mugo NR, Tenet V, van Kemenade FJ, Rana FS, Sakr SR, Meijer CJ, Snijders PJ, Franceschi S.

Int J Cancer. 2013 Sep 15;133(6):1441-6. doi: 10.1002/ijc.28131. Epub 2013 Mar 16.

34.

Outcomes of a tuberculosis contact investigation programme in Italy.

Migliore E, Borraccino A, Baussano I, Piccioni P, Carosso A, Bugiani M.

Eur Respir J. 2012 Nov;40(5):1291-3. doi: 10.1183/09031936.00047312. No abstract available.

35.

Evaluation of immigrant tuberculosis screening in industrialized countries.

Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A.

Emerg Infect Dis. 2012 Sep;18(9):1422-9. doi: 10.3201/eid1809.120128.

36.

Tuberculosis among health care workers.

Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F.

Emerg Infect Dis. 2011 Mar;17(3):488-94. doi: 10.3201/eid1703.100947. Review.

37.

HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions.

Baussano I, Ronco G, Segnan N, French K, Vineis P, Garnett GP.

Epidemics. 2010 Mar;2(1):21-8. doi: 10.1016/j.epidem.2010.02.002. Epub 2010 Feb 10.

PMID:
21352773
38.

Tuberculosis incidence in prisons: a systematic review.

Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F.

PLoS Med. 2010 Dec 21;7(12):e1000381. doi: 10.1371/journal.pmed.1000381. Review.

39.

Modelling patterns of clearance of HPV-16 infection and vaccination efficacy.

Baussano I, Garnett G, Segnan N, Ronco G, Vineis P.

Vaccine. 2011 Feb 1;29(6):1270-7. doi: 10.1016/j.vaccine.2010.11.082. Epub 2010 Dec 8.

PMID:
21145375
40.

[Health of immigrants in Italy: increasing evidences and forgotten issues in the epidemiological research].

Fedeli U, Baussano I.

Epidemiol Prev. 2010 May-Jun;34(3):120-4. Italian.

PMID:
20852349
41.

[Mathematical models of infection transmission].

Baussano I, Bianco S, Lazzarato F.

Epidemiol Prev. 2010 Jan-Apr;34(1-2):56-60. Italian.

PMID:
20595738
42.

Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis.

Arshad S, Bavan L, Gajari K, Paget SN, Baussano I.

Eur Respir J. 2010 Jun;35(6):1336-45. doi: 10.1183/09031936.00054709. Epub 2009 Oct 19. Review.

43.

Variability of adenoidectomy/tonsillectomy rates among children of the Veneto Region, Italy.

Fedeli U, Marchesan M, Avossa F, Zambon F, Andretta M, Baussano I, Spolaore P.

BMC Health Serv Res. 2009 Feb 7;9:25. doi: 10.1186/1472-6963-9-25.

44.

Predicting tuberculosis treatment outcome in a low-incidence area.

Baussano I, Pivetta E, Vizzini L, Abbona F, Bugiani M.

Int J Tuberc Lung Dis. 2008 Dec;12(12):1441-8.

PMID:
19017455
45.

Does language matter? A case study of epidemiological and public health journals, databases and professional education in French, German and Italian.

Baussano I, Brzoska P, Fedeli U, Larouche C, Razum O, Fung IC.

Emerg Themes Epidemiol. 2008 Sep 30;5:16. doi: 10.1186/1742-7622-5-16.

46.

[Incidence of tuberculosis in Piedmont Region in the period 2001-2003].

Baussano I, Abbona F, Veljkovic A, Bugiani M.

Epidemiol Prev. 2008 Mar-Apr;32(2):85-92. Italian.

47.

Continuous positive airway pressure for treatment of respiratory complications after abdominal surgery: a systematic review and meta-analysis.

Ferreyra GP, Baussano I, Squadrone V, Richiardi L, Marchiaro G, Del Sorbo L, Mascia L, Merletti F, Ranieri VM.

Ann Surg. 2008 Apr;247(4):617-26. doi: 10.1097/SLA.0b013e3181675829. Review.

PMID:
18362624
48.

Feasibility of recruiting a birth cohort through the Internet: the experience of the NINFEA cohort.

Richiardi L, Baussano I, Vizzini L, Douwes J, Pearce N, Merletti F; NINFEA cohort.

Eur J Epidemiol. 2007;22(12):831-7. Epub 2007 Oct 23.

PMID:
17955333
49.

Expected number of childhood cancers in Italy from 2001 to 2015.

Baussano I, Maule MM, Dama E, Dalmasso P, Mosso ML, Galzerano M, Merletti F, Magnani C, Pastore G.

Haematologica. 2007 Sep;92(9):1258-61.

50.

Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.

Baussano I, Tardivo I, Bellezza-Fontana R, Forneris MP, Lezo A, Anfossi L, Castello M, Aleksandar V, Bignamini E.

Pediatrics. 2006 Sep;118(3):888-95.

PMID:
16950978

Supplemental Content

Loading ...
Support Center